Drawing for KAPPA

USPTO serial 74638847

KAPPA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
WARD, JOYCE A.
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KAPPA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CHARLES E. BAXLEY

CHARLES E BAXLEY HART, BAXLEY, DANIELS & HOLTON59 JOHN ST FIFTH FLNEW YORK, NY 10038UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for use in treatment of dermatological disorders, cardiac disorders, respiratory disorders, cancers and the common coldABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 20, 1996ABN1ABANDONMENT - EXPRESS MAILED—
Sep 23, 1996CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 1996CNSLLETTER OF SUSPENSION MAILED—
Feb 21, 1996CNSLLETTER OF SUSPENSION MAILED—
Nov 29, 1995CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 29, 19951.BDSec. 1(B) CLAIM DELETED—
Jul 21, 1995CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 1995DOCKASSIGNED TO EXAMINER—
Jul 19, 1995DOCKASSIGNED TO EXAMINER—
Jul 14, 1995DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance